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Hy ertension Does Not Affect Intracellular 
Ca P cium Uptake in Human Platelets 
Marc Eberhnd, Domirzique Eutf9uoz, md Paul Erue 
The relationship between the Ca’+ transport of 
platelet endoplasmic reticulum and hypertension 
was analyzed in 17 untreated patients exhibiting 
various degrees of hypertension. Each patient un- 
derwent a 24-h recording of ambulatory blood 
press~e. Platelets from patients wew permeabi- 
lized with saponin and the rate of ATP-driven 
thapsigargin-sensitive Ca2+ uptake det.::mined us- 
ing the fluorescent Ca’+ indicator flue-3. No rela- 
tionship behveen blood pressure (systolic, diastol- 
ic, day, night) and the rate of CaZC uptake into the 
-- __---- 
sacmplasmic reticulum of platelets was found. A 
weak but insignificant correlation between Ca’+ 
uptake and the heart rate was noted. Therefore, the 
increase in cytosolic Ca2+ of platelets in hyperten- 
sion may not be dw to changes of the activity of 
Ca2+ uptake into the sacroplasmic reticulum. Am J 
Hypertens 1996;9:136-142 
KEY WJRDS: Platelets, calcium transport, 
hypertension. 
D espite extensive research, the relationship of calcium and arterial hypertension re- mains unclear. intracellular Ca” is a major determinant of basal myogenic tone of vas- 
cular muscle. 1 herefore, an increase of cytosolic Ca” 
in arterial smooth muscle leads to an increase in pe- 
ripherai resistance characteristic for hypertension. The 
systemic hormonal signals associated with hyperten- 
sion influence endothelial cell, vascular muscle cells 
and blood cells. Eme et al’ have dwJmented an ele- 
vation of platelet cytosolic frw 6” in hypertension 
and a close correlation of the CL’- levels in platelets 
and blood pressure in untreated h 
Y+ 
pertensive pa- 
tients. Furthermore. both platelet Ca and vasocon- 
striction were normalized by antihypertensive treat- 
ment,‘,2 indicating a close relationsh’ip between plate- 
__-_- -_.-__-___ 
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let Ca’+ dynamics and circulating hormonal factors. 
Cytosolic Ca2+ overload has been desctibed in a vari- 
ety of cells in both hypertensior?s and pressure- 
induced cardiac dysfunction.” 
Whereas the relationship of platelet qtosolic Ca” 
and rasoconshiction has been clearly established, the 
mo!eccular basis of elevated Ca” levels remain, un- 
clear. The rapid rise in cytosolic Ca2’ observed upon 
exposure of platelets to humoral factors from hyper- 
tensives’,” indicates that systemic hormonal fac!ors in- 
fluence platelet cytosolic Ca’- and that the changes in 
platelet cytoso!ic Ca’+ are effected by a rapid mecha- 
nism, ie. Ca” influx across the plasma membrane or 
intracellular Ca” mobilization. The reversal of Ca” 
levels by means of Ca” antagonists has led to the 
hypothesis that Ca’* iflux is responsible for elevated 
platelet Ca”.‘,Y However, the enhanced hormone- 
induced elevation of platelet cytosolic Ca” is not cor- 
rected by antihypertensii e therapy,‘” demonstrating 
that the fundamental defect in Ca“ dvnamics has not 
been restored. .\loreover, witage-operated Ca’- chan- 
nels do not mediate agonist-evoked Ca” entry in 
platelets. ” E&ides voltage-operated Ca” channels. a 
variety of other mechanisms cw;tibutr to the Ca2’ 
dynamics of platelcts!‘~“: agonist-mediate.1 Ca” in- 
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Bux; l&and-g&d Ca’+ channels; Ca”-ATPare pumps 
present in both the plasma membrane and membrane 
of endoplasmic reticulum”,“; Na+/Ca*+ exchanger”; 
inositol 1,4,5+isphosph.&-induced Ca” rele.lse from 
intracellular Ca” stem: and a series of cytojolic and 
endoplasmic reticulum Ca’* binding proteins. Resink 
et allh have documented a reduction of the calmodu- 
linstimulated Ca’+-ATPaw activity and an increase in 
basal Ca”-ATPase activity in platelets from hyperten- 
sive compared to normal subjects, suggesting a reduc- 
tioq in plasma membrane Ca’+ exhusion activity and 
an activation of the sarcoplasmic reticulum Ca*+ pump 
in hypertension. Other studies also have desctibed a 
decrease in Ca”-ATPase activity in hypertension.“,” 
In the present study we have determined the rate of 
Ca” uptake in permeabilited platelets from 17 un- 
heated subjects with various degrees of hypertension 
in order to test if alteration of the sarcoplasmic retic- 
ulum Ca”-ATPase pump activity contributes to ele- 
vated platelet .$osolic Ca” in hypertension. 
MATERIALS AND METHODS 
Reagents Heparin, pentosan polysulfate, sapanin, 
and hexokinase were obtained from Sigma (St. Louis, 
MO). Rue-3 pentapotassium salt was from Molecular 
Probes (Eugene. OR). Flue-3 was stored in 50 pL ali- 
quots at a concentration of 1 mmol/L in dimethylsulf- 
oxide at -70°C. Ionomycin was from Calbiochem (San 
Diego, CA!, thapsigargin from LC Services Corpora- 
tion. Aminoethyl Biogel P-2 was purchased from Bio- 
Rad (Richmond, CA), and Sepharose CL-2B from 
Pharmacia (Uppsala, Sweden). 
Buffer Solutions All experiments were performed 
in 20 mmol/L HEPES buffer containing 155 mmol/L 
KCI, 5 mmol/L NaCl, 2 mmol/L MgCl,, 2 mmol/L 
I&dithioetythritol, and 0.3 mmol/L phenylmethane- 
sulfonyl fluoride at pH 7.2, which was denoted buffer 
A. All solutions were depleted of Ca” by means of 
chromatography on EDTA-polyacrylamide as de- 
scribed previously.“,” Residual Ca” concentrations 
of solutions following treatment with EDTA- 
polyacrylamide were measured as described.20 
Patients We analyzed platelets of 17 newly diag- 
nosed hypertensive patients who were referred ta the 
Division of Cardiology of the Kantonsspital Lucerne. 
None of the patients had received antihypertensive 
drugs before. Patients underwent a ltlead electcocar- 
diagram, a bicycle exercise test, and a 24-h recording 
of ambulatory blood pressure (HCR Blood Pressure, 
Disectru?ic, Burgdorf, Switzerland). Table 1 summa- 
rizes the clinical data and results of ambulatory 24-h 
blood pressure measuremenk. 
preparation of Platelets Platelets were prepared 
from platelet-rich plasma by gel filtration*’ using 
Sepharose CL-2B (Pharmacia) and adjusted to 108 
TABLE 1. CLINICAL PARAMETERS OF THE 
SE’IENTF.EN PATIENTS SUBJECIXD TO 24 H BLOOD 
PRESSURE DETERMINATION 
Gender (men/women) 
Age (years) 
Height (cm) 
Weight (kg) 
Office SBP (mm Hg) 
Office DBP (mm Hg) 
Day SBP (mm Hg) 
Day DBP (mm Hg) 
Night SBP (mm Hg) 
Night DBP (mm Hg) 
Day heart rate (beats/min) 
Night heart rate (heats/min) 
13/5 
48+13 
171flO 
75+14 
169f27 
111f12 
148f16 
97flO 
136f20 
87f9 
76f7 
6426 
cells/ml. Platelets were permeabiiized by addition of 
20 kg saponin/l08 cells. Selective permeabilization 
was confirmed by measuring the release of flue-3 from 
cells loaded with flue-3 acetoxymethyl ester, and by 
monitoring the release of Ca” horn internal mem- 
branes in permeabilized cells following addition of 
ionomycin. Platelets were used within 6 h of blood 
withdrawal. 
Measurement of Ca’+ Ca” concentrations were 
measured by means of the fluorescent Ca” indicator 
Buo-3. The indicator was added at a final concentra- 
tion of 1 bmol/L to 1 mL of a suspension of platelets 
(108 cells/ml) placed into a l-cm quartz cuvettc. The 
suspension was continuously stirred using a magnetic 
stirrer. Fluorescence was measured by means of a Per- 
kin-Elmer (Oakbrook, IL) 650-10s fluorimeter, inter- 
faced via an analog/digital converter (PC-28, Inshu- 
matic AG, Zurich, Switzerland) to a personal com- 
puter. Ruorescence of tluo-3 was excited at 505 nm 
and observed at 530 nm. ATP (1 mmol/L) and saponin 
(20 llg) were added to the cell suspension to activate 
Ca” uptake of intracellular Ca” stores. ATP at 1 
mm~ol/L was found to saturate thapsigargin-sensitive 
Ca2’ uptake in platelets from many subjects of widely 
different degrees of hypertension (not shown). 
Ca’+ concentrations were calculated frvn the fll;~ 
rescence signal using standard tikations of flue-3 with 
Ca2’. Binding of Ca” to flue-3 was expressed as signal 
versus concentration of added Ca”, and evalu&ed as 
describecLm From the dissociation constant (Kd) of the 
Ca’+-flu+3 complex, which was typically 900 nmol/L 
in buffer A. the fluorescence signal of Ca*+-free indi- 
cator (f,) and that of the Ca”-indicator complex (f,), 
the concentration of Ca” w.:s calcukted 3:. foIlor*-s: 
ICa2’l hn = Kd l Cf, - f,,/Cf,zc - f,, (1) 
where f, represents the observed fluo-ce signal. 
K, was determined from tibations of flu-3 with Ca’+ 
(final concentrations between 0 and 5 mmol/L; eval- 
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uation according to Eberhard and Ernt?‘?. f, was de- 
termined after addition of EGTA (5 mmol/Lj, and tFc 
by extrapolation of the concentration of added Ca2’ to 
infinity. Figure 1 illustrates the calibration of fluores- 
cence. The Ca2’ flux due to the sarcoplasmir reticulum 
Ca”-ATl’ase pump, hence termed Cal’ uptake, was 
determined from the difference of the overall Ca’+ flux 
before and after addition of ?hapsigargin (200 nmol/ 
L), a specific inhibitor of the sarcoplasmic reticulum 
CaZ’-ATPase.22 In the presence of thapsigargi:l, a 
spontaneous Ca” flux out of the sarcoplasmic reticu- 
lum, the so-called leak, was observed and modelled by 
an exponential decay toward an equilibrium value 
(Figure IB): 
[Ca”] = n * exp(-k . t) + [Ca*‘l, (2) 
where R and k are arbitrary consiants, and [Ca”],, the 
equilibrium concentration of Ca”. Thus, the rate of 
Ca” leak at a particular Ca” concentration is given by 
Data Analysis Data evaluation and nonlinear least- 
squares fits were performed using standard proce- 
dures.2”2J Results are expressed as means + SD. I:ldi- 
vidual Ca” uptake and leak rate deterr%natiuns were 
averaged and SD ..x!*:s calculated if three or more 
individual values were measured. Linear least-squares 
resressions assuming uniform and unity SD values of 
the individual data points were used to analyze puta- 
tive relationships between binding data and clinical 
parameters. Percentile points 8’) were determined us- 
ing the two-tailed t distribution. 
RESULTS 
d[Ca”l/dt = -k l n. exp(-k * t) = -k * 
uca2+1 - ICa2’iog) 
The evaluatioil of fl:orescmce dat‘r and a typical Ca” 
transient used to datermine Ca” uptake rates, i.e. the 
(3) thapsigargin-sensitive Ca” flux, are shown in Figure 
The rate of Ca” uptake is the difference bet ~veen the 
slop of the Ca” transient at a particular Ca’- concen- 
tration before addition o! thapsigargin (overal: Ca” 
flux, Figure I), and the rate of Ca” leak at that Cd’- 
concentration (equation 3). 
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1. At a given Ca” concentration similar Ca” uptake 
rates were obtained when thapsigargin was added at 
various degrees of store !oading (not shown). Since 
Ca” concentrations of suspensions of pemwabilized 
platelet were around and above 1 mmol/L, and since 
the Ca*’ uptake rate did not significantly depend on 
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the concentration of Ca” in the range behveen 0.8 and 
1.5 mmol/L (not shown), Ca’+ uptake rates were eval- 
uated at 1 mmol/L Ca” in the present study. To ex- 
amine if spontaneous Ca” leak of the Ca” stores is 
linked to hypertension, the Ca2+ leak (Ca2’ flux in the 
presence of thapsigargin) was also evaluated at 1 
mmol/L Ca”. In two out of the 17 patients examined 
the CaZ’ concentration of the platelet suspension after 
permeabilization was too high to allow the determi- 
nation of Ca” uptake and leak rates at ! mmol/L Ca”. 
Figure 2 shows that Cai’ uptake into sarcoplasmic 
reticulum is not related to average daytime blood 
pressure. Similar results are obtained with otter blood 
pressure parameters (Table 1) and with Ca” leak from 
sarcoplasm~c rr:ix~lum (Tabie 2). A weak correlation 
between both Ca’+ uptak.e and Ca’+ leak and heart rate 
was observed (Figure 3, Table 2). although these cor- 
relations are flawed by the substantial error of the 
values of Ca” uptake and leak. Furthermore, no cor- 
relation was found behveen Ca” uptake and age (Ta- 
ble 2). To corroborate the relationship between Ca” 
fluxes and blood pressure we analyzed a group of 
blood donors consisting of four normotensive and ten 
hypertensive subjects who did not undergo 24-h blood 
pressure determination (Table 3). No significant cor- 
relation between flux parameters and blood pressure 
was detected within this group (not shown). In addi- 
tion, the differences in Ca” uptake and leak between 
the group of normotmsives and the two hypertensive 
groups were statistically not significant (Table 3). 
DISCUSSION 
There is a general agreement that plate!& cytosolic 
Ca” is increased in hypertension and that this process 
can be accomplished by rapid Ca’+-regulating pro- 
cesses.’ Both plasma membrane- and internal mem- 
brane-associated Ca’+ fluxes contribute to the ob- 
served changes in platelet cytosolic Ca”. Since the 
Ca’+-ATPase of sarcoplasmic reticulum is believed to 
represent the major contribution to Ca’+ remw;al from 
the cytoplasm,“,” xe have analyzed ATP-dependent 
TABLE 2. CORRELATION OF Ca’+ UPTAKE AND LEAK WITH CLINICAL PARAMETERS __-- .__~ 
Ca’* Uptake Ca’+ Leak - 
PaIaUl&l Slope P r Sl0pe P r 
Aw 0.063 A 0.055 >.2 0.389 0.043 f 0.029 >.I 0.383 
Day SBr a.025 ? 0.060 >.5 -0.114 0.010 f 0.031 >.5 0.093 
Day DBP 0.011 fO.lO1 >.5 0.029 a.003 t 0.053 >.5 a.015 
Night SBP 0.019 i 0.044 ..5 0.121 0.012 + 0.023 >.5 0.141 
Night DBP 0.130 A 0.086 >.l 0.3% 0.027 f 0.048 >.j 0.155 
Day heart rate 0.141 f 0.113 >.2 0.327 0.105 f 0.055 >.05 0.465 
Night heart rate 0.260 f 0.096 co5 0.591 0.124 * 0.054 co5 0.541 ~- 
I5 kVprtnsla plimls wrd~plnx 2-h blood ptnsuw d&nGdion (TabIt I), for which Ca-‘* ~P!,I~I rind C$’ Imk ralur; uwc dclenind (UC 
~UItsJ. 
SBP, systolic blcai presun: DEP. dtastohc blood pmrun. 
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Ca” transport into sarcopl3smic reticulum in platelets 
from a series of patients exhibiting various degrees of 
hypertension. None of the patients received antihy- 
pertensive therapy prior to analysis. Thapsigargin, a 
specific inhibitor of all isoforms of internal membrane 
GI~‘-ATP~s~‘~~~~, served to evaluate C&-A rPase 
transport activity and spontaneous Ca*+ leak of sarco- 
plasmic reticulum. No correlation of blood pressure 
with both CP” sptake and CL?’ leak and a weak but 
insignificant correlation of Ca” uptake with heart rate 
were found. Ca” uptake and Ca” leak did not signif- 
icantly differ between hypertensive pntients and a 
normotensive control group. 
An earlier study has documented a substantial in- 
crease of platelet calmodulin-insensifve Cd”-ATPase 
acti\ ity in ‘lypertension ” indicating a stimulation of 
internal membrane Ca”-ATPase in hypertension. 
The discrepancy to our results may result from the 
different selection of hypertensive patien!s, the xse of 
thapsig?rgin in the present study as opposed to cal- 
modulir. activation, and the determination oi Ca” 
transpo: t activities in permeabilized cells in the 
present .?xperiments rather than Ca’--dependent AT- 
Pase artisitv in membrane preparations used in the 
spldy of R&ink et a1.16 Takaya et al” found a decrease 
in maximal velocity and Michaelis constant of Ca”- 
ATPase in platelets from hypertensive patients. Since 
plasma membrane and internal membrane Ca”- 
ATPase activity was nor discriminated, the respective 
contributions of the two Ca”’ pumps could not ‘be 
evaluated in that shrdy. In agreement with our results, 
no correlation of platelet sarcoplasmic reticulum Cn’+- 
ATPase with blood pressure was documented, but a 
decrease of platelet plasma membrane Ca2+-ATPase 
activity in hypertension was found recently.‘” Consis- 
tent with the decrease in calmodulin-sensitive Ca’+- 
ATI’ase activity in hypertension,16 these studies indi- 
cate that removal of Ca” across the plasma membrane 
is responsible for the well established rise of cytosolic 
Ca” in hypertension.‘,’ 
Possible other mechanisms accounting for altered 
cytosolic Ca*’ in hypertension include increased ago- 
nist-induced 6” influx,‘O activation of voltage- 
operated Ca’+ channels,] altered inositol 1,4,5- 
trispho;fhate-induced Ca*’ efflux from internal Ca” 
stores, and a decreased activity of G+/Ca’+ 
exchangers present in the platelet plasma mem- 
brane.“,*’ Whereas the density of voltage-g&d Ca’+ 
channels in platelets is very low and plays only a mi- 
nor role in the Ca” balance of platelets,” enhanced 
agonist-induced 6” influx in platelets has been doc- 
umepted in patients with ischemic heart diseaw3 A 
TABLE 3. COMPARISON OF Ca*+ UPTAKE AND LEAK BETWEEN HYPERTENSIVE PATIENTS ANV 
NORMOTENSIVE SUBJECTS 
- 
Normotensive Hypertensive Hypertensive’ 
Gmup (n = 4) -in = 10) (n = 15) 
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decrease of platelet Na’/K’-ATPase activity in mild 
gestational hypertension has been suggested to con- 
tribute to increased cytosolic Ca” through the Na+/ 
Ca’+ exchanger.” However, Takaya et al” did not 
find altered platelet Na’/K*-ATPase activity in hyper- 
tension. Therefore, a decreased activity of the plasma 
membrane Ca’+-ATPase and increased agonist- 
induced Ca” influx are likely to contribute to the in- 
crease in plate& cytosolic Ca” in hypertension, 
whereas ATPdriven Ca” uptake into internal Ca” 
stores remains rather unchanged. 
In thzz present study a weak relationship between 
Ca” uptake into internal membrarzes and heart rate 
was noted (Figure 3). Clearly, more patients and a 
wider range of heart rates will be needed to decide if 
this correlation is significant. A link between heart 
rate, which is controlled by the sympathetic and para- 
sympathetic nervous system,w”.” and Ca2+ dynamics 
of the platelet wrcoplasmic reticulum could be pad- 
renergic receptors present in the heart and on plate- 
lets.Jz,33 Whereas hypertension is usually associated 
with an increase in sympathetic activity,” its role in 
the Ca” balance in platelets remains obscure, al- 
though Padrenergic receptors may affect Ca’+ pump- 
ing activity via phospholamban phosphorylation.” 
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